Your browser doesn't support javascript.
loading
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.
Yam, Clinton; Abuhadra, Nour; Sun, Ryan; Adrada, Beatriz E; Ding, Qing-Qing; White, Jason B; Ravenberg, Elizabeth E; Clayborn, Alyson R; Valero, Vicente; Tripathy, Debu; Damodaran, Senthilkumar; Arun, Banu K; Litton, Jennifer K; Ueno, Naoto T; Murthy, Rashmi K; Lim, Bora; Baez, Luis; Li, Xiaoxian; Buzdar, Aman U; Hortobagyi, Gabriel N; Thompson, Alistair M; Mittendorf, Elizabeth A; Rauch, Gaiane M; Candelaria, Rosalind P; Huo, Lei; Moulder, Stacy L; Chang, Jeffrey T.
Affiliation
  • Yam C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Abuhadra N; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Adrada BE; Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ding QQ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • White JB; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravenberg EE; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Clayborn AR; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Damodaran S; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Arun BK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Murthy RK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lim B; Department of Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Baez L; PROncology (Private Practice), University of Puerto Rico, San Juan, Puerto Rico.
  • Li X; Department of Pathology & Laboratory Medicine, Winship Cancer Institute - Emory University Hospital, Atlanta, Georgia.
  • Buzdar AU; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thompson AM; Section of Breast Surgery, Division of Surgical Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Rauch GM; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Candelaria RP; Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huo L; Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moulder SL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang JT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 28(13): 2878-2889, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35507014
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States